Jabra Zarka | Medicine and Dentistry | Best Researcher Award

Best Researcher Award

Jabra Zarka
Affiliation Mayo Clinic
Country United States
Scopus ID 57217183871
Documents 13
Citations 222
h-index 7
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0001-8668-6741

Jabra Zarka

Mayo Clinic, United States

The Best Researcher Award recognizes distinguished scholarly achievement, scientific productivity, and meaningful contributions to the advancement of knowledge. Jabra Zarka, affiliated with Mayo Clinic in the United States, has established a notable research profile in the fields of medicine and dentistry through peer-reviewed publications, interdisciplinary collaborations, and measurable scientific impact. The research metrics associated with this profile, including publications, citations, and h-index values, indicate sustained engagement in scientific inquiry and academic dissemination.[1]

Abstract

This article presents an academic overview of Jabra Zarka’s scholarly profile in recognition of nomination for the Best Researcher Award at the World Science Awards. The assessment considers bibliometric indicators, publication activity, scientific influence, and contributions to medical research. The available metrics indicate an active and productive research career characterized by interdisciplinary engagement and measurable citation impact.[1]

Keywords

Best Researcher Award; Medical Research; Bibliometrics; Scientific Impact; Scopus Author Profile; Research Excellence; Citation Analysis; Medicine and Dentistry; Scholarly Publications; Academic Recognition.

Introduction

Academic awards play an important role in recognizing individuals whose research contributes significantly to scientific advancement and societal development. Bibliometric indicators, including publication counts and citation metrics, are widely used to evaluate research performance and scholarly influence.[2] Jabra Zarka’s scientific profile demonstrates sustained contributions to medicine and dentistry through peer-reviewed research outputs and academic collaboration.

Research Profile

Jabra Zarka is affiliated with Mayo Clinic, one of the internationally recognized medical research institutions in the United States. The research profile indexed in Scopus identifies 13 scholarly documents that have collectively received 222 citations, resulting in an h-index of 7.[1] These indicators suggest a meaningful level of academic engagement and the dissemination of research findings within the scientific community.

  • Affiliation with Mayo Clinic, United States.
  • Research specialization in Medicine and Dentistry.
  • Indexed publications and measurable citation impact.
  • Active scholarly presence through international dissemination.

Research Contributions

The scientific contributions of Jabra Zarka are reflected through publications addressing contemporary issues in medicine and healthcare. The research outputs have contributed to scientific understanding and have attracted citations from subsequent studies, demonstrating relevance and influence within the academic community.[3]

  • Production of peer-reviewed scientific articles.
  • Contribution to interdisciplinary medical research.
  • Participation in evidence-based scientific investigations.
  • Dissemination of knowledge through indexed journals.

Publications

The publication record indexed under the Scopus Author ID demonstrates scholarly productivity and continuous engagement with scientific communication. Publications in internationally indexed journals contribute to the visibility and accessibility of research findings and facilitate knowledge transfer among researchers and practitioners.[1]

  1. Peer-reviewed articles in medicine and dentistry.
  2. Collaborative scientific publications with interdisciplinary authors.
  3. Research outputs indexed in major academic databases.

Research Impact

Research impact is commonly assessed through bibliometric indicators and citation analyses that provide evidence of scientific influence and knowledge dissemination.[2] With 222 citations and an h-index of 7, the scholarly profile of Dr. Jabra Zarka reflects a measurable and growing academic impact within the field of medicine and dentistry.

Award Suitability

The Best Researcher Award seeks to recognize researchers who demonstrate scientific excellence, sustained scholarly productivity, and measurable impact. Based on the available bibliometric indicators and documented publication record, Jabra Zarka’s academic profile aligns with the principles of research recognition promoted by the World Science Awards.[4]

Conclusion

Jabra Zarka has developed a notable scholarly profile characterized by research productivity, citation influence, and contributions to medicine and dentistry. The documented bibliometric indicators and publication achievements provide evidence of scientific engagement and support recognition through the Best Researcher Award at the World Science Awards. Continued research activity and dissemination are expected to further strengthen this academic profile.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Jabra Zarka, Author ID 57217183871. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57217183871
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
    https://doi.org/10.1073/pnas.0507655102
  3. Garfield, E. (2006). The history and meaning of the journal impact factor. Journal of the American Medical Association.
    https://doi.org/10.1001/jama.295.1.90

Peijie He | Medicine and Dentistry | Innovation Excellence Award

Prof. Dr. Peijie He | Medicine and Dentistry | Innovation Excellence Award

ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

Professor Peijie He, MD, PhD, is a senior surgeon, clinician-scientist, and academic leader in laryngology and head & neck surgery at the Eye and ENT Hospital of Fudan University, Shanghai. As Chief Physician of the Division of Laryngology, his career integrates advanced clinical practice, translational research, and postgraduate medical education, with a sustained focus on function-preserving treatment strategies for laryngeal and hypopharyngeal diseases. His academic training spans China and South Korea, combining clinical otolaryngology with laser medicine and photodynamic therapy, which has shaped his distinctive interdisciplinary research profile. Professor He has made substantial contributions to minimally invasive laryngeal surgery, phonosurgery, and laser-based therapies, particularly the clinical application of CO₂ and KTP lasers, photodynamic therapy, and office-based interventions for vocal fold leukoplakia, papillomatosis, hemangioma, and early-stage laryngeal carcinoma. His work bridges clinical innovation with mechanistic research, elucidating oxidative stress, ROS-mediated pathways, and apoptosis mechanisms in laryngeal cancer cells, thereby strengthening the scientific foundation of modern laryngological treatments. He has authored and co-authored over 30 peer-reviewed international publications in leading journals such as The Laryngoscope, Journal of Voice, European Archives of Oto-Rhino-Laryngology, Lasers in Medical Science, and Oncology Letters, with multiple papers as corresponding author. His research is frequently cited and widely recognized within the otolaryngology community. Professor He has served as Principal Investigator on multiple competitive grants, including projects funded by the National Natural Science Foundation of China and the Shanghai Municipal Health Commission, supporting both basic and clinically translational research.

Citation Metrics (Scopus)
600
500
300

100

Citations
602
Documents
52
h-index
14

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Maria Sundvall | Medicine and Dentistry | Best Researcher Award

Dr. Maria Sundvall | Medicine and Dentistry | Best Researcher Award

University of Turku, Finland

Dr. Maria Sundvall is a distinguished physician-scientist and academic leader in Clinical Oncology and Molecular Cancer Biology, renowned for her translational research bridging laboratory discoveries with clinical applications. She earned her Medical Doctor degree in 2003, followed by a Ph.D. in Medical Biochemistry and Molecular Biology from the University of Turku, Finland, in 2007, where her thesis focused on “Signaling of ErbB4 Isoforms in Cancer.” She was later awarded the Title of Docent in 2015 and became a Specialist Physician in Clinical Oncology and Radiotherapy in 2018. Professionally, Dr. Sundvall serves as a Consultant in Clinical Oncology at Turku University Hospital and a Clinical Lecturer at the Institute of Biomedicine, University of Turku, where she also directs the Cancer Research Unit. Her earlier career includes postdoctoral research at Harvard Medical School under Professor P.P. Pandolfi, where she advanced her expertise in oncogenic signaling and targeted cancer therapies. Her research interests focus on receptor tyrosine kinase signaling, metabolic vulnerabilities in cancer, resistance mechanisms to EGFR-targeting therapies, and precision oncology for breast and prostate cancers. Dr. Sundvall possesses advanced research skills in molecular biology, cell signaling, cancer genomics, and translational medicine, with proficiency in various laboratory and clinical trial methodologies. She has authored over 34 publications in prestigious journals such as PNAS, Cancer Research, Clinical Cancer Research, and Oncogene, contributing key insights into cancer mechanisms and therapeutic resistance. Her numerous honors include the Turku University Foundation Ph.D. Thesis Award and research grants exceeding €1 million from the Research Council of Finland, the Finnish Medical Foundation, and the Sigrid Juselius Foundation. In conclusion, Dr. Sundvall exemplifies excellence in research, teaching, and clinical innovation, with her work significantly advancing the understanding of cancer biology and influencing future directions in precision oncology and patient-centered cancer care worldwide.

Profiles: Scopus | ORCID | LinkedIn

Featured Publications

Sriraman, S., Virtanen, V., Kukkula, A., Toriseva, M., Lumiainen, A., West, G., Poutanen, M., Taimen, P., & Sundvall, M. (2025). Androgen receptor‐mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer. The Journal of Pathology. Advance online publication.

Koskela, S., Pulkkinen, O., Mehmood, A., Kallionpää, R., Birkman, E.-M., Huuhtanen, J., Mustjoki, S., Coupland, S., Aittokallio, T., & Sundvall, M. (2025, July 8). Novel anti-PD1 predictive signature and functional dendritic-cell biomarkers in melanoma identified with systems immunology [Preprint]. Research Square.

Gnjatovic, J., Garces Ibanez, J., Rantala, J., Sundvall, M., Alanne, E., Vaittinen, S., Mattila, P., Jäättelä, M., & Hämälistö, S. (2025, April 29). Patient-derived lymphoma organoids and repurposed drugs: Novel solutions for improved B cell lymphoma treatment [Conference paper].

Hollmén, M., Löyttyniemi, E., Juhanoja, E., Vihinen, P., & Sundvall, M. (2025, February). High comorbidity and tumor proliferation predict survival of localized breast cancer patients after curative surgery: A retrospective analysis of real-world data in Finland. Surgical Oncology, 102(188).

Nissi, L., Tuominen, S., Routila, J., Huusko, T., Ketonen, P., Sundvall, M., Leivo, I., Irjala, H., Minn, H., & Grönroos, T. J. (2024, November). xCT as a predictor for survival in a population‐based cohort of head and neck squamous cell carcinoma. Cancer Medicine.